NWF Advisory Services’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$371K Buy
+4,110
New +$240K 0.03% 271
2024
Q2
– Sell
-7,455
Closed -$280K – 344
2024
Q1
$280K Buy
7,455
+3,239
+77% +$142K 0.05% 236
2023
Q4
$236K Buy
+4,216
New +$183K 0.05% 234
2023
Q3
– Sell
-4,299
Closed -$240K – 303
2023
Q2
$240K Hold
4,299
– – 0.06% 213
2023
Q1
$240K Buy
+4,299
New +$201K 0.06% 212

Other funds holding TXG

NWF Advisory Services's TXG Position: Q3 2026 in Review

NWF Advisory Services opened a new position in 10x Genomics (TXG) in Q3 2026: 4,110 shares worth $371K. The stake represents 0.03% of the portfolio and ranks #271 among its holdings. This is a return to the name: NWF Advisory Services previously reported a position in TXG as recently as Q1 2024.

NWF Advisory Services first reported a position in TXG in Q1 2023 and has held it in 5 quarters since. 84 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • NWF Advisory Services held 4,110 shares of 10x Genomics worth $371K as of Q3 2026.
  • 10x Genomics was a new NWF Advisory Services position in Q3 2026.
  • 10x Genomics made up 0.03% of NWF Advisory Services's portfolio in Q3 2026, its #271 holding.
  • NWF Advisory Services first reported a position in 10x Genomics in Q1 2023 and has held it in 5 quarters since.
  • 84 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on NWF Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.